Zim Corp (ZIMCF)
0.00
USD |
OTCM |
Apr 24, 16:00
Price Chart
Key Stats
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 99.93% |
Profile
| Zim Corp has sold its operations and is currently focused on biomedical research. The company focused all of its resources on developing intellectual property and advancing research and development in the areas of new synthetic drugs and immunotherapies. It generates geographic revenue from Canada. |
| URL | https://www.zim.biz |
| Investor Relations URL | N/A |
| HQ State/Province | Ontario |
| Sector | Information Technology |
| Industry | Software |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Zim Corp has sold its operations and is currently focused on biomedical research. The company focused all of its resources on developing intellectual property and advancing research and development in the areas of new synthetic drugs and immunotherapies. It generates geographic revenue from Canada. |
| URL | https://www.zim.biz |
| Investor Relations URL | N/A |
| HQ State/Province | Ontario |
| Sector | Information Technology |
| Industry | Software |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |